Skip to content

Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01876407
Enrollment
126
Registered
2013-06-12
Start date
2013-01-31
Completion date
2016-07-31
Last updated
2016-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Mucositis

Brief summary

The purpose of this study is to evaluate the effectiveness of using to low intensity laser as an intervention against preventive and therapeutic oral mucositis induced by radiotherapy and chemotherapy.

Interventions

DEVICELow intensity laser for oral mucositis
DEVICELow intensity laser for oral mucositis switch off

Low intensity laser for oral mucositis switch off

Sponsors

Fundación Pública Andaluza Progreso y Salud
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with squamous cell carcinoma of the oral cavity. * Patients aged between 18 and 80 years. * Patients who are to receive one of the following treatment * Combined radiotherapy (conventional fractionation 70 Gy reaching the tumor and affected lymph nodes, and 50 Gy in the areas ganglion drainage) and chemotherapy (cisplatin 100 mg/m2 IV on days 1, 22 and 43 irradiation or cetuximab 400mg/m2 as a single dose pre-load radiotherapy and 250mg/m2 weekly for the same. Regardless of whether they have received previous surgical treatment. * Treatment with radiotherapy of 70 Gy in 35 daily sessions 2Gy/día consecutive. * Patients who voluntarily express their intention to participate by informed consent.

Exclusion criteria

* Patients who denied informed consent. * Patients who have hypersensitivity or allergy to any of the components included in the study. * Patients diagnosed with HIV, and autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
Evaluate the effectiveness of using low-intensity laser compared with placebo as preventive and therapeutic intervention of oral mucositis induced by radiation therapy and chemotherapy.24 months

Secondary

MeasureTime frame
Evaluate the effectiveness of using low level laser compared with placebo in the prevention of onset of oral mucositis induced by treatment of head and neck QRT.24 months
Evaluate the effectiveness of the use of low laser intensity versus placebo in improving the healing of oral mucositis induced by treatment of head and neck QRT.24 months
Evaluate the effectiveness of using low level laser compared with placebo in reducing pain during and after cancer treatment.24 months
Evaluate the effectiveness of using low level laser compared with placebo in analgesic use during and after cancer treatment.24 months
Assess the intervention tolerance and side effects of it.24 months

Countries

Spain

Contacts

Primary ContactDaniel Torres Lagares
danieltl@us.es
Backup ContactMaría del Mar Benjumea Vargas
gestionensayosclinicos.fps@juntadeandalucia.es955 04 04 50

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026